Progyny Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Progyny Inc.
- Former names
- Auxogyn, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 8090 — Services-Misc Health & Allied Services, NEC
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- PGNY
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001551306
- EIN
- 27-2220139
Board of directors
- Since 2023
-
Cheryl Scott · DirectorSince 2023
-
David J. Schlanger · Director · Executive ChairmanSince 2023
-
Debra L. Morris · DirectorSince 2025
-
Elizabeth D. Bierbower · DirectorSince 2025
- Since 2023
-
Jeffrey G. Park · DirectorSince 2023
-
Kevin K. Gordon · DirectorSince 2023
-
Lloyd H. Dean · DirectorSince 2023
-
Norman Payson · DirectorSince 2023
-
Peter Anevski · Director · CHIEF EXECUTIVE OFFICERSince 2023
-
Roger C. Holstein · DirectorSince 2023
Chief executives
Peter Anevski
· CHIEF EXECUTIVE OFFICER
Dates unknown
Director election results
Annual meeting of May 21, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
76.2%
-
77.1%
-
80.9%
Board connections
7 of this board's directors also sit on 15 other boards.
- via Beth C. Seidenberg and Fred E. Cohen
- via Beth C. Seidenberg
- via Debra L. Morris
- via Fred E. Cohen
- via Cheryl Scott
- via Fred E. Cohen
- via Beth C. Seidenberg
- via Lloyd H. Dean
- via Elizabeth D. Bierbower
- via Jeffrey G. Park
- via Debra L. Morris
- via Beth C. Seidenberg
- via Lloyd H. Dean
- via Fred E. Cohen
- via Beth C. Seidenberg
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,931,055
- 1 purchase by 1 insider
- Sold, last 12 months
- $2,160,542
- 22 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 17, 2026 | Clapp Geoffrey Officer (Chief Product Officer) | Shares withheld for tax | −819 | $27.38 | $22,424 |
| Sep 10, 2026 | Kevin K. Gordon Director | Option exercise | +22,000 | $13.00 | $286,000 |
| Sep 10, 2026 | Kevin K. Gordon Director | Shares withheld for tax | −10,500 | $27.24 | $286,020 |
| Sep 10, 2026 | Kevin K. Gordon Director | Open-market sale | −11,500 | $27.94 | $321,358 |
| Sep 4, 2026 | Livingston Mark S. Officer (CHIEF FINANCIAL OFFICER) | Shares withheld for tax | −479 | $26.61 | $12,746 |
| Sep 4, 2026 | Swartz Allison Officer (EVP, GC) | Shares withheld for tax | −479 | $26.61 | $12,746 |
| Sep 3, 2026 | Peter Anevski Director, Officer (CHIEF EXECUTIVE OFFICER) | Shares withheld for tax | −5,361 | $26.29 | $140,941 |
| Sep 3, 2026 | Swartz Allison Officer (EVP, GC) | Shares withheld for tax | −828 | $26.29 | $21,768 |
| Sep 3, 2026 | Livingston Mark S. Officer (CHIEF FINANCIAL OFFICER) | Shares withheld for tax | −1,532 | $26.29 | $40,276 |
| Sep 2, 2026 | Livingston Mark S. Officer (CHIEF FINANCIAL OFFICER) | Shares withheld for tax | −224 | $25.66 | $5,748 |
| Aug 28, 2026 | Swartz Allison Officer (EVP, GC) | Shares withheld for tax | −1,352 | $25.86 | $34,963 |
| Jul 14, 2026 | Cummings Melissa B Officer (Chief Operating Officer) | Shares withheld for tax | −1,193 | $31.98 | $38,152 |
| Jul 14, 2026 | Cummings Melissa B Officer (Chief Operating Officer) | Open-market sale | −2,244 | $31.60 | $70,910 |
| Jun 17, 2026 | Clapp Geoffrey Officer (Chief Product Officer) | Shares withheld for tax | −819 | $26.60 | $21,785 |
| Jun 4, 2026 | Livingston Mark S. Officer (CHIEF FINANCIAL OFFICER) | Shares withheld for tax | −339 | $24.99 | $8,472 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.